Literature DB >> 23375015

Advances in the mechanisms of Parkinson's disease.

Christopher M Tolleson1, John Y Fang.   

Abstract

Parkinson's disease is the second most common neurodegenerative disorder. Despite fairly typical clinical and pathologic features, the etiology remains unknown. Many cellular mechanisms such as oxidative stress, mitochondrial dysfunction, lysosomal dysfunction, neuroinflammatory changes, and the formation of pathologic inclusions have been proposed as potential causes. Potential links between environmental and genetic changes appear to predispose individuals to develop Parkinson's disease. Considering these observations, albeit with different levels of evidence, it is becoming more probable that Parkinson's disease is a heterogeneous disorder or a syndrome that arises from the contribution of many different factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375015

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  20 in total

1.  Neuroprotective Role of MicroRNA-22 in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via Regulation of Its Target Gene TRPM7.

Authors:  Chao Ping Yang; Zhen Hua Zhang; Li Hua Zhang; Han Chen Rui
Journal:  J Mol Neurosci       Date:  2016-09-08       Impact factor: 3.444

2.  Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a C. elegans model of Parkinson's disease.

Authors:  Jacob Boos; Ahmed Shubbar; Werner J Geldenhuys
Journal:  Med Chem Res       Date:  2021-04-09       Impact factor: 2.351

3.  Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice.

Authors:  Fengju Jia; Ning Song; Chenyang Zhao; Junxia Xie; Hong Jiang
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

4.  Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP.

Authors:  Chen Lu; Jin Zhang; Xiaopeng Shi; Shan Miao; Linlin Bi; Song Zhang; Qian Yang; Xuanxuan Zhou; Meng Zhang; Yanhua Xie; Qing Miao; Siwang Wang
Journal:  Int J Biol Sci       Date:  2014-03-13       Impact factor: 6.580

Review 5.  Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.

Authors:  Sarah van Veen; Danny M Sørensen; Tine Holemans; Henrik W Holen; Michael G Palmgren; Peter Vangheluwe
Journal:  Front Mol Neurosci       Date:  2014-05-27       Impact factor: 5.639

Review 6.  Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.

Authors:  Anmu Xie; Jing Gao; Lin Xu; Dongmei Meng
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

7.  Involvement of Mu Opioid Receptor Signaling in the Protective Effect of Opioid against 6-Hydroxydopamine-Induced SH-SY5Y Human Neuroblastoma Cells Apoptosis.

Authors:  Shahrzad Eftekhar-Vaghefi; Saeed Esmaeili-Mahani; Leila Elyasi; Mehdi Abbasnejad
Journal:  Basic Clin Neurosci       Date:  2015-07

8.  Epicatechin Reduces Striatal MPP⁺-Induced Damage in Rats through Slight Increases in SOD-Cu,Zn Activity.

Authors:  M Rubio-Osornio; E Gorostieta-Salas; S Montes; F Pérez-Severiano; C Rubio; C Gómez; C Ríos; J Guevara
Journal:  Oxid Med Cell Longev       Date:  2015-08-02       Impact factor: 6.543

9.  Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.

Authors:  Qian Sun; Tian Wang; Tian-Fang Jiang; Pei Huang; Dun-Hui Li; Ying Wang; Qin Xiao; Jun Liu; Sheng-Di Chen
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

10.  Identification of key genes and pathways in Parkinson's disease through integrated analysis.

Authors:  Jingru Wang; Yining Liu; Tuanzhi Chen
Journal:  Mol Med Rep       Date:  2017-07-31       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.